HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Complete in vivo reversal of the multidrug resistance phenotype by jet-injection of anti-MDR1 short hairpin RNA-encoding plasmid DNA.

Abstract
Triggering the RNA interference (RNAi) pathway by inducing the expression of short hairpin RNA (shRNA) molecules has become a promising tool for efficient silencing of a given gene in gene therapy applications. In this study, shRNA encoding DNA was utilized to reverse the classical MDR1/P-glycoprotein (MDR1/P-gp)-mediated multidrug resistance (MDR) phenotype in vivo. For the first time, the nonviral jet-injection technology was applied for delivering naked shRNA-vector constructs for direct intratumoral in vivo transfer. The highly efficient anti-MDR1 shRNA expression vectors were applied twice in the human MDR1/P-gp overexpressing MaTu/ADR cancer xenograft-bearing mice, and twice in the corresponding drug-sensitive parental MaTu tumor xenograft bearing mice as well. Two days after anti-MDR1 shRNA vector injection, the expression level of the MDR1 messenger RNA (mRNA) was decreased by more than 90% and the corresponding MDR1/P-gp protein was no longer detectable in the tumors. Two jet-injections of anti-MDR1 shRNA vectors into the tumors, combined with two intravenous (IV) administrations of doxorubicin, were sufficient to achieve complete reversal of the drug-resistant phenotype. The data show that jet-injection delivery of shRNA-expressing vectors is effective in reversing MDR1/P-gp-mediated MDR in vivo, and is therefore a promising strategy for making tumors with an MDR1/Pgp-dependent MDR phenotype revert to a drug-sensitive state.
AuthorsUlrike Stein, Wolfgang Walther, Alexandra Stege, Alexander Kaszubiak, Iduna Fichtner, Hermann Lage
JournalMolecular therapy : the journal of the American Society of Gene Therapy (Mol Ther) Vol. 16 Issue 1 Pg. 178-86 (Jan 2008) ISSN: 1525-0024 [Electronic] United States
PMID17878902 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • ABCB1 protein, human
  • ATP Binding Cassette Transporter, Subfamily B
  • ATP Binding Cassette Transporter, Subfamily B, Member 1
  • DNA, Neoplasm
  • RNA, Messenger
  • RNA, Neoplasm
Topics
  • ATP Binding Cassette Transporter, Subfamily B
  • ATP Binding Cassette Transporter, Subfamily B, Member 1 (antagonists & inhibitors, biosynthesis, genetics)
  • Animals
  • DNA, Neoplasm (administration & dosage, genetics)
  • Drug Resistance, Multiple (genetics)
  • Drug Resistance, Neoplasm (genetics)
  • HeLa Cells
  • Humans
  • Injections, Intralesional
  • Injections, Jet
  • Mammary Neoplasms, Experimental (genetics, metabolism, therapy)
  • Mice
  • Mice, Nude
  • Phenotype
  • Plasmids (administration & dosage)
  • RNA, Messenger (antagonists & inhibitors, biosynthesis)
  • RNA, Neoplasm (administration & dosage, genetics)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: